Results 281 to 290 of about 1,232,473 (312)

Hyperuricaemia and type 2 diabetes mellitus

Clinical and Experimental Pharmacology and Physiology, 2018
SummaryChoi et al reported the effect of hyperuricaemia on the new‐onset type 2 diabetes mellitus (T2DM). I present three queries. (i) Insulin is considered to stimulate uric acid reabsorption via specific transporter and the effect of hyperuricaemia on the new‐onset T2DM should be evaluated by considering insulin resistance. (ii) There is a limitation
openaire   +2 more sources

Genes and type 2 diabetes mellitus

Current Diabetes Reports, 2008
In 2007, five whole genome-wide association studies were published on the genetics of type 2 diabetes mellitus (T2DM), followed by the discovery of 11 genes consistently associated with T2DM. This breakthrough provided the first glimpses of a complete picture of the disease's genetic complexity.
Leif, Groop, Valeriya, Lyssenko
openaire   +2 more sources

Genetics of type 2 diabetes mellitus

Diabetes Research and Clinical Practice, 2005
The clinical picture of type 2 diabetes mellitus (T2DM) is formed by impairment in insulin secretion and resistance to insulin action. As a result of intensive efforts of the scientists around the world mutations and polymorphisms in a number of genes were linked with monogenic and polygenic forms of T2DM.
openaire   +2 more sources

Type 2 Diabetes Mellitus

Diabetes Technology & Therapeutics, 2000
E, Moghissi, J, Mestman
openaire   +2 more sources

Pathogenesis of Type 2 Diabetes Mellitus

Archives of Medical Research, 2005
The pathological sequence for type 2 diabetes is complex and entails many different elements that act in concert to cause that disease. This review proposes a sequence of events and how they interact by a careful analysis of the human and animal model literature.
openaire   +2 more sources

[Insulin and type 2 diabetes mellitus].

Therapeutische Umschau. Revue therapeutique, 2009
Worldwide an increasing number of persons suffers from type 2 diabetes. Often treatment with oral hypoglycemic agents is not sufficient for adequate glycemic control and additional insulin treatment is necessary. Treatment with insulin is recommended if HbA1c levels below 7% cannot be achieved despite lifestyle measures and the proper use of oral ...
Lanker, Andrea Daniela, Müller, Bruno, Diem, Peter   +2 more
openaire   +2 more sources

Screening for Type 2 Diabetes Mellitus

Annals of Internal Medicine, 2015
Shelley, Selph, Ian, Blazina, Roger, Chou   +2 more
openaire   +4 more sources

Rosiglitazone and type 2 diabetes mellitus

The Lancet, 2001
openaire   +2 more sources

Diabetes and Cancer: A Consensus Report

Ca-A Cancer Journal for Clinicians, 2010
Edward Giovannucci, Susan M Gapstur, Laurel A Habel   +2 more
exaly  

Preventing Cancer, Cardiovascular Disease, and Diabetes: A Common Agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association

Ca-A Cancer Journal for Clinicians, 2004
Richard Kahn, Rose Marie Robertson, Yuling Hong   +2 more
exaly